Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine

Xuelian Wang1, Hannah N Coleman, Uma Nagarajan

  • 1Department of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.

Vaccine
|October 19, 2013
PubMed

Insights

Candida enhances human papillomavirus (HPV) vaccine immune responses by promoting Langerhans cell maturation and T-cell proliferation. This study investigated how Candida acts as an adjuvant to boost vaccine efficacy for HPV therapeutic vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Dermatology

Background:

  • Effective cell-mediated immunity induction by vaccine adjuvants remains a challenge.
  • Candida skin test reagent shows potential in inducing regression of common warts.
  • A novel therapeutic vaccine for human papillomavirus (HPV) utilizes a peptide-based approach combined with Candida as a potential adjuvant.

Purpose of the Study:

  • To elucidate the mechanisms by which Candida enhances immune responses to a peptide-based HPV therapeutic vaccine.
  • To investigate the effects of the vaccine and Candida on Langerhans cells, T-cell proliferation, cytokine expression, and pattern recognition receptors.
  • To assess the induction of Th1, Th2, and Th17 responses in healthy subjects.

Main Methods:

  • Analysis of Langerhans cell maturation markers (CD40, CD80) following treatment with the HPV vaccine and Candida.
  • Assessment of T-cell proliferation capacity when presented by Langerhans cells in vitro.
  • Quantification of cytokine profiles (mRNA and protein) and evaluation of pattern recognition receptor expression in Langerhans cells.

Main Results:

  • The HPV vaccine peptides induced partial maturation of Langerhans cells, evidenced by increased CD40 and CD80 expression.
  • Candida was identified as the primary driver of T-cell proliferation, while peptides mediated Langerhans cell maturation.
  • Interleukin-12p40 (IL-12p40) mRNA was frequently induced, and IL-12p70 protein was detected; Th1 response induction was limited.

Conclusions:

  • The study delineates the distinct roles of HPV peptides and Candida in modulating Langerhans cell and T-cell responses.
  • Candida acts as a potent inducer of T-cell proliferation, a crucial component for cell-mediated immunity.
  • The findings support the potential of Candida as a novel adjuvant for enhancing the efficacy of peptide-based therapeutic vaccines, particularly for HPV.